The University of Chicago Header Logo

Connection

Hans Schreiber to Histocompatibility Antigens Class I

This is a "connection" page, showing publications Hans Schreiber has written about Histocompatibility Antigens Class I.
  1. Long-term persistence of CD4(+) but rapid disappearance of CD8(+) T cells expressing an MHC class I-restricted TCR of nanomolar affinity. Mol Ther. 2012 Mar; 20(3):652-60.
    View in: PubMed
    Score: 0.367
  2. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J Exp Med. 1997 Jul 21; 186(2):229-38.
    View in: PubMed
    Score: 0.135
  3. Targeting cancer-specific mutations by T cell receptor gene therapy. Curr Opin Immunol. 2015 Apr; 33:112-9.
    View in: PubMed
    Score: 0.114
  4. Immunodominance and tumor escape. Semin Cancer Biol. 2002 Feb; 12(1):25-31.
    View in: PubMed
    Score: 0.046
  5. MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR. Cancer Immunol Immunother. 2013 Feb; 62(2):359-69.
    View in: PubMed
    Score: 0.024
  6. Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen. J Exp Med. 1990 Apr 01; 171(4):1205-20.
    View in: PubMed
    Score: 0.020
  7. Highly immunogenic regressor tumor cells can prevent development of postsurgical tumor immunity. Cell Immunol. 1989 Mar; 119(1):101-13.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.